Scientists have developed a simple test that can identify 18 early-stage cancers that experts say could represent a medical “gamechanger.”
Cancer accounts for one in every six deaths worldwide, but early detection can significantly improve outcomes.
Existing screening tests have drawbacks, including invasiveness, cost and low levels of accuracy for early stage disease.
Photo: EPA-EFE
Now US researchers have designed a test that analyses proteins in the blood and can pick up 18 early stage cancers, representing all main organs in the human body.
Specific blood proteins could already be used for early detection and monitoring, but until now tests have lacked sensitivity — accuracy of picking up those with cancer — and specificity — accuracy of excluding those without cancer, the researchers said.
The team, from the US biotech firm Novelna, said their test outperformed others relying on tumor DNA in the blood, and had “a sensitivity much greater” than the Galleri test being trialed on the NHS in the UK.
Photo: AFP
By looking at proteins in blood plasma, the experts were able to differentiate cancer samples from normal ones, and even distinguish between different types of cancers “with high accuracy,” they said. The research also found evidence that cancer protein signals were likely to be sex-specific.
Writing in the journal BMJ Oncology, the team said: “This finding is the foundation for a multi-cancer screening test for the early detection of 18 solid tumors that cover all major human organs of origin for such cancers at the earliest stage of their development with high accuracy.”
They added: “This could re-shape screening guidelines, making this plasma test a standard part of routine check-ups.”
Photo: AP
“These findings pave the way for a cost-effective, highly accurate, multi-cancer screening test that can be implemented on a population-wide scale.”
Blood plasma samples were collected from 440 people diagnosed with 18 different types of cancer, and from 44 healthy blood donors.
The team then identified proteins which showed early stage cancers and where they originated in the body “with high accuracy.”
The team wrote: “At stage I (the earliest cancer stage) and at the specificity of 99 percent, our panels were able to identify 93 percent of cancers among males and 84 percent of cancers among females.
“Our sex-specific localization panels consisted of 150 proteins and were able to identify the tissue of origin of most cancers in more than 80 percent of cases.”
Analysis of the plasma protein also showed almost all of them were present at very low levels. This shows the importance of low-level proteins to pick up pre-cancerous and early stage disease before a tumor has had time to cause substantial damage, the team said.
But the team said their relatively small sample size meant further studies were needed in bigger groups of people.
Mangesh Thorat, of the Centre for Cancer Prevention at the Wolfson Institute of Preventive Medicine, who was not involved with the study, said there remained questions about the test and more studies were needed.
“However, the interesting aspects of this assay are a much higher sensitivity for stage I cancers than other similar assays in development and gender-specific performance differences which are biologically and clinically relevant,” he said.
“If the assay performance in future, well-designed sequential studies is anywhere close to what this preliminary study suggests, then it could really be a gamechanger.”
Prof Paul Pharoah, a cancer epidemiology expert at Cedars-Sinai Medical Center, who was also not involved in the study, welcomed the findings but urged caution.
“Simple blood tests that can detect many different cancers in the early stages (test is sensitive) and do not generate false positives (test is specific) are a holy grail for early detection,” he said.
“This paper reports on the initial results of the development of one such test. While the results show some promise, it is far too soon to be confident that this test will turn out to be useful for early cancer detection.”
On the final approach to Lanshan Workstation (嵐山工作站), logging trains crossed one last gully over a dramatic double bridge, taking the left line to enter the locomotive shed or the right line to continue straight through, heading deeper into the Central Mountains. Today, hikers have to scramble down a steep slope into this gully and pass underneath the rails, still hanging eerily in the air even after the bridge’s supports collapsed long ago. It is the final — but not the most dangerous — challenge of a tough two-day hike in. Back when logging was still underway, it was a quick,
From censoring “poisonous books” to banning “poisonous languages,” the Chinese Nationalist Party (KMT) tried hard to stamp out anything that might conflict with its agenda during its almost 40 years of martial law. To mark 228 Peace Memorial Day, which commemorates the anti-government uprising in 1947, which was violently suppressed, I visited two exhibitions detailing censorship in Taiwan: “Silenced Pages” (禁書時代) at the National 228 Memorial Museum and “Mandarin Monopoly?!” (請說國語) at the National Human Rights Museum. In both cases, the authorities framed their targets as “evils that would threaten social mores, national stability and their anti-communist cause, justifying their actions
In the run-up to World War II, Admiral Wilhelm Canaris, head of Abwehr, Nazi Germany’s military intelligence service, began to fear that Hitler would launch a war Germany could not win. Deeply disappointed by the sell-out of the Munich Agreement in 1938, Canaris conducted several clandestine operations that were aimed at getting the UK to wake up, invest in defense and actively support the nations Hitler planned to invade. For example, the “Dutch war scare” of January 1939 saw fake intelligence leaked to the British that suggested that Germany was planning to invade the Netherlands in February and acquire airfields
The launch of DeepSeek-R1 AI by Hangzhou-based High-Flyer and subsequent impact reveals a lot about the state of the People’s Republic of China (PRC) today, both good and bad. It touches on the state of Chinese technology, innovation, intellectual property theft, sanctions busting smuggling, propaganda, geopolitics and as with everything in China, the power politics of the Chinese Communist Party (CCP). PLEASING XI JINPING DeepSeek’s creation is almost certainly no accident. In 2015 CCP Secretary General Xi Jinping (習近平) launched his Made in China 2025 program intended to move China away from low-end manufacturing into an innovative technological powerhouse, with Artificial Intelligence
RSS